Each year the United States experiences a shortage of over 100 drugs, many of which are sterile injectable products for life-threatening conditions like septic shock and cancer. In an editorial in this week’s issue of JAMA, CP3 co-director Julie Donohue, PhD, and her colleague Derek Angus, MD, MPH, explore the reasons for drug shortages and discuss potential solutions.